Literature DB >> 10846852

The provision of a semen cryopreservation service for male cancer sufferers in the Republic of Ireland.

D Keane1, S Naughton, K Waite, R F Harrison.   

Abstract

BACKGROUND: Chemotherapy, radiotherapy and surgery for cancer all carry risks of sterility. Semen cryopreservation would allow procreational ability to be preserved.
METHODS: A human-assisted reproduction unit was set up in the Rotunda Hospital where semen was cryopreserved and stored for use.
RESULTS: Semen was frozen for procreational potential during 1998 from 58 males about to have oncology therapy likely to render them sterile. The planning for this service and the modus operandi now in place are described. While cryopreservation was not unsuccessful in any case, substandard samples were obtained from 14 men. Pre-freeze viral tests tested positive for CMV in six patients. One pregnancy is already on-going utilising IVF with thawed semen. One patient's death has been notified and the frozen semen disposed of.
CONCLUSION: The service is, at present, outside public purse provision. It is hoped that in the near future this will change, as the deficit between charges and costs cannot be sustained in-house forever.

Entities:  

Mesh:

Year:  2000        PMID: 10846852     DOI: 10.1007/bf03170478

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  10 in total

1.  Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes.

Authors:  E Porcu; R Fabbri; R Seracchioli; P M Ciotti; O Magrini; C Flamigni
Journal:  Fertil Steril       Date:  1997-10       Impact factor: 7.329

2.  Successful fertilization and pregnancy outcome in in-vitro fertilization using cryopreserved/thawed spermatozoa from patients with malignant diseases.

Authors:  E Khalifa; S Oehninger; A A Acosta; M Morshedi; L Veeck; R G Bryzyski; S J Muasher
Journal:  Hum Reprod       Date:  1992-01       Impact factor: 6.918

3.  Establishing an intracytoplasmic sperm injection (ICSI) programme for the treatment of male factor infertility in Ireland.

Authors:  A C Gordon; R F Harrison; A McMahon; M Fawzy
Journal:  Ir J Med Sci       Date:  1997 Apr-Jun       Impact factor: 1.568

Review 4.  The effects of cancer and cancer therapy on male fertility.

Authors:  J V Thachil; M A Jewett; W D Rider
Journal:  J Urol       Date:  1981-08       Impact factor: 7.450

5.  Testicular cancer and spermatogenesis.

Authors:  A Botchan; R Hauser; L Yogev; R Gamzu; G Paz; J B Lessing; H Yavetz
Journal:  Hum Reprod       Date:  1997-04       Impact factor: 6.918

6.  Effects of cancer on spermatozoa quality after cryopreservation: a 12-year experience.

Authors:  O F Padron; R K Sharma; A J Thomas; A Agarwal
Journal:  Fertil Steril       Date:  1997-02       Impact factor: 7.329

7.  Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation.

Authors:  W F Hendry; J Stedronska; C R Jones; C A Blackmore; A Barrett; M J Peckham
Journal:  Br J Urol       Date:  1983-12

8.  Does patient semen quality alter during an in vitro fertilization (IVF) program in a manner that is clinically significant when specific counseling is in operation?

Authors:  L Drudy; R Harrison; J Verso; E Cottell; U Kondaveeti; C Barry-Kinsella; A Gordon
Journal:  J Assist Reprod Genet       Date:  1994-04       Impact factor: 3.412

9.  Effect of cryoprotective media and dilution methods on the preservation of human spermatozoa.

Authors:  M Mahadevan; A O Trounson
Journal:  Andrologia       Date:  1983 Jul-Aug       Impact factor: 2.775

10.  Cryopreservation and semen quality in patients with Hodgkin's disease.

Authors:  M Shekarriz; M V Tolentino; I Ayzman; J C Lee; A J Thomas; A Agarwal
Journal:  Cancer       Date:  1995-06-01       Impact factor: 6.860

  10 in total
  1 in total

1.  Initial experiences of a testicular sperm extraction programme for assisted reproduction in Ireland.

Authors:  S Jacob; H Spillane; D Keane; K Waite; G McSorley; R F Harrison
Journal:  Ir J Med Sci       Date:  2000 Jan-Mar       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.